Notice Type
Departmental
Consent to the Distribution of New Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution inNew Zealand of the new medicines set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Anastrozole 1 mg Tablet Zeneca Pharmaceuticals Group, Newark, Delaware, United States of America Arimidex Atropine sulphate 600 mcg in 1 mL, 1,200 mcg in 1 mL Injection, polyamp Delta West Pty Limited, Bentley, Western Australia, Australia Atropine Sulphate Piroxicam--cyclodextrin 191.2 mg equivalent to 20 mg piroxicam Tablet Chiesi Pharmaceuticals S p A, Parma, Italy Brexin Piroxicam--cyclodextrin 191.2 mg equivalent to 20 mg piroxicam Granules for oral suspension Chiesi Pharmaceuticals S p A, Parma, Italy Brexin Dextromethorphan hydrobromide 10 mg, guaiphenesin 200 mg, pseudoephedrine hydrochloride 30 mg Capsule R P Scherer Corporation, Saint Petersburg, Florida, United States of America and R P Scherer Holdings Pty Limited, Braeside, Victoria, Australia Dimetapp Cold, Cough and Sinus Liquid Caps Dextromethorphan hydrobromide 10 mg, guaiphenesin 100 mg, paracetamol 250 mg, pseudoephedrine hydrochloride 30 mg Capsule R P Scherer Corporation, Saint Petersburg, Florida, United States of America and R P Scherer Holdings Pty Limited, Braeside, Victoria, Australia Dimetapp Cold, Cough and Flu Liquid Caps Brompheniramine maleate 0.40 mg, dextromethorphan hydrobromide 2 mg, phenylephrine hydrochloride 1 mg Liquid Wyeth Australia Pty Limited, Smithfield, New South Wales, Australia Dimetapp DM Cold and Cough Elixir Dobutamine hydrochloride 14.01 mg/mL equivalent to 12.5 mg/mL dobutamine base in 20 mL Injection, vial Abbott Laboratories, Rocky Mount, North Carolina, United States of America Dobutamine Hydrochloride Dobutamine hydrochloride 0.5 mg, 1 mg, 2 mg per mL in 250 mL and 500 mL Solution for infusion, plastic bag Abbott Laboratories, North Chicago, Illinois, United States of America Dobutamine in 5% dextrose Sodium citrate 450 mg, sodium lauryl sulphoacetate 45 mg in 5 mL Enema E C De Witt & Company Limited, Manor Park, Runcorn, Cheshire, England Fleet Micro-enema Sodium perborate 2 g Powder, contact lens solution Laboratoria Smeets B V B A., Antwerp, Belgium Liprofin Benzalkonium chloride 6.0% w/w, paraffin liquid light 52.5% w/w, triclosan 2.0% w/w Solution, topical Stiefel Laboratories (Ireland) Limited, Sligo, Ireland Oilatum Plus Citric acid 12 g, light magnesium oxide 3.5 g, sodium picosulphate 5 mg Powder, oral solution Ferring A B., Malmo, Sweden Pico-Salax Dated this 7th day of August 1996. HUGH BABER, Assistant General Manager, Health Regulation and Protection, pursuant to delegation given by the Minister of Health on the 18th day of January 1996.
Publication Date
15 Aug 1996

Notice Number

1996-go5209

Page Number

2259